BRAVE foundation model excludes 70-77% of negative breast biopsy and frozen-section cases with NPV above 0.95 while improving balanced accuracy from 88.5% to 95.1% in reader studies and predicting survival outcomes.
C.et al.Human epidermal growth factor receptor 2 testing in breast cancer: Asco-college of american pathologists guideline update.J
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.CV 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
A Breast Vision Pathology Foundation Model for Real-world Clinical Utility
BRAVE foundation model excludes 70-77% of negative breast biopsy and frozen-section cases with NPV above 0.95 while improving balanced accuracy from 88.5% to 95.1% in reader studies and predicting survival outcomes.